Get Permission R Sree Naga Sowndary and Kavitha E: Comparative bateriological profile with antibiotic resistance pattern among diabetic and non-diabetic patients


Introduction

Diabetes Mellitus a global disease, which was declared as an epidemic in developing countries where there is insulin deficiency causing increased blood glucose level. Approximately 347 million people are suffering from Diabetes Mellitus worldwide, which would be double by the year 2025.1 With increased blood glucose level, there is always a lack of enough nutrients and oxygen to the energizing cells which reduces the normal functional activity of immune system and increases the process of inflammation in the body cells.1 Reduced process of wound healing leads to the peripheral arterial diseases and peripheral neuropathy causing reduced circulation and reduced oxygen supply, essential in the wound healing process.

Hyperglycemia facilitates growth of many organisms as well as colonization by bacterial and fungal pathogens.2 Commonly isolated organisms include Staphylococcus aureus, Gram negative bacteria like Escherichia coli, Pseudomonas aeruginosa, Klebsiellaspecies, Proteus species and anaerobic organisms. These infections are mostly polymicrobial with serious complications.3

On comparing the microbial profile of diabetic wound to that of non-diabetic wound, the severity of infection can be seen much aggravated among diabetic patients. This condition brings in recurrence of infection which further results in more comorbid conditions.4 Once an infection has developed in diabetic patients, it is difficult to treat because of impairment in microvascular circulation that limits phagocytic cell action and curtails the reach of antibiotics to the infected sites.5

Early diagnosis of diabetic wound infection is required for the antimicrobial therapy. This study is expected to generate valuable information, which will be helpful in the management and prevention of diabetic infection in our population and will guide clinicians in the management of such condition with appropriate as well as judicious use of antimicrobial therapy.

Materials and Methods

The present study was a cross-sectional type of study, carried out in the Department of Microbiology for a period of two months between October to November 2018. The study was started after getting institutional ethics clearance from the College. A total of 100 wound swab or pus samples were collected from 50 diabetic patients and 50 non-diabetic patients of any age group for the study. To avoid contamination, wound and tissue debris were thoroughly cleaned with sterile normal saline followed by gentle rubbing of the wound site with 70% alcohol prior to swabbing the pus sample.

Samples were collected in sterile screw- capped containers and were transported to the laboratory immediately. If it was wound swab, two swabs were collected per patient where one was used for microscopy (Gram’s staining) and the other for routine conventional culture method. Blood was also collected for biochemical analysis for the estimation of glycemic index.

Samples were properly labeled and transported to the laboratory for further investigation. In further methodology, the identification of aerobic bacteria and detection of its antimicrobial susceptibility was performed by Kirby Bauer disk diffusion method as per the Clinical and Laboratory Standards Institute (CLSI) guidelines 2017.6 Extended spectrum beta-lactamases (ESBL) positive organisms were screened by observing an increase ≥ 5mm in zone diameter with ceftazidime/clavulanate versus its zone size when tested with ceftazidime disc alone.7 Resistance to methicillin was tested using the cefoxitin disc (30µg) by disc diffusion method. An inhibition zone diameter of ≤ 21mm in case of Staphylococcus aureus and ≤24 mm for coagulase negative Staphylococcus was considered as methicillin resistant organisms.

Results

A total of 100 samples accounting for 50 diabetic and 50 no-diabetic were included for the study. The study population represented 70% male whereas 30% as female patients. The mean age of the patients was 52.31years ranging from 11 to 99 years. All patients presented with ulcers which were graded 0-5 in the Wagner classification and majority belonged to Grade 2 (i.e., deep ulcer, penetrating down to ligaments and muscles, but no bone involvement or abscess formation).8, 9

Among the total 100 samples, 55% were wound swabs and 45% accounted for the pus samples received from the surgery department. All the samples showed bacterial growth of aerobic bacteria. The distribution of bacteriological profile is shown in the Table 1, Table 2.

Table 1

Distribution of bacterial isolates among the clinical samples (N=100)

Organism N (%)
Gram positive bacteria
Staphylococcus aureus (MS)a 6
Staphylococcus aureus (MR)b 20
Enterococcus spp 8
Coagulase negative Staphylococcus 6
Streptococcus spp 5
Gram Negative bacteria
Pseudomonas aeruginosa 16
Proteus mirabilis 14
Escherichia coli 8
Klebsiella pneumoniae 6
Acinetobacter spp 6
Atypical E.coli 5
Total 100 (100%)

[i] aMS- methicillin- sensitive; bMR- methicillin resistant

Table 2

Percentage distribution of organisms among the clinical isolates

Organism DM-wound Non-DM wound
Gram positive cocci
Staphylococcus aureus 14% 12%
Enterococci 3% 5%
Streptococcus 3% 2%
Staphylococcus ( coagulase –ve) 1% 5%
Gram negative bacilli
Proteus mirabillus (ESBL) 10% 4%
Pseudomonas aeruginosa 8% 8%
E.coli 6% 2%
Klebsiella pneumoniae (ESBL) 5% 1%
Acinetobacter 4% 2%
Atypical E.coli 4% 1%

Our study showed polymicrobial distribution of infection and it was found to be about 32% among the total samples. The most common organism isolated was Staphylococcus aureus in both diabetic and non-diabetic wound samples. There was 45% of gram positive isolates whereas 55% were identified as gram negative isolates. Among all the isolates, Staphylococcus aureus was the most frequent pathogen (26%), followed by Pseudomonas aeruginosa (16%) and Proteus mirabilis (14%).

Among the gram positive organisms, Staphylococcus aureus (57.8%) was most frequent in which 6% were found to be methicillin resistant staphylococcus aureus (MRSA). The second commonest pathogen in gram positive organism was Enterococcus spp (17.8%) followed by coagulase negative staphylococci (13.3%) which are mainly recognized as normal commensals.

Pseudomonas aeruginosa (29%) was the predominant pathogen isolated among the gram negative organisms followed by Proteus mirabilis (25.4%) and Escherichia coli (14.5%).

In-vitro antibiotic susceptibility pattern are depicted in Table 3 & 4. All gram positive isolates were sensitive towards vancomycin and linezolid. Also, Fusidic acid was found to be efficient against all Staphylococcus species including the methicillin resistant isolates. Among the gram negative, most of the isolates were sensitive to Amikacin, Cotrimoxazole and Imipenem. Only one isolate of Acinetobacter spp (1.8%) showed resistance towards Imipenem.

The total Methicillin Resistant Staphylococcus aureus was 6%, in which both diabetic and non-diabetic wound was about 3% each. The total extended spectrum beta lactamases organism in our study was about 23% among which 16% was diabetic whereas only 7% was non-diabetic.

On comparison among diabetic wound, the glycaemic index was poorly controlled wherein fasting blood glucose level was found to be >150mg/dL in 37 patients and postprandial blood glucose level was about >210mg/dL in 41 patients. These patients also found to have polymicrobial growth of microbial pathogens which were resistant to most of the antibiotics.

Table 3

In-vitro susceptibility pattern of Gram positive organisms (N= 45) to various antimicrobials (%)

Organism ERY CIP COT AZIT CD VAN LZ FA
Staphylococcus aureus (MS)a 3 80 54 54 48 61 100 100 100
Staphylococcus aureus (MR)b 0 54 26 50 52 29 100 100 100
Enterococcus spp 12 29 81 74 27 75 100 100 100
Staphylococcus (coagulase negative) 0 83 75 39 48 81 100 100 100
Streptococcus spp 4 65 69 49 51 29 100 100 100

[i] aMS- methicillin- sensitive; bMR- methicillin resistant

[ii] P-penicillin; ERY- erythromycin; CIP- ciprofloxacin; COT- cotrimoxazole; AZIT-azithromycin, CD- clindamycin, VAN- vancomycin, LZ-linozolid; FA-fusidic acid

Table 4

In-vitro susceptibility pattern of Gram negative organisms (N= 55) to various antimicrobials (%)

Organism AK CTX CIP COT AMC IPM ATM CES
Pseudomonas aeruginosa 65 25 54 57 10 100 89 89
Proteus mirabilis 59 65 26 95 47 100 59 69
Escherichia coli 85 57 81 86 52 100 69 100
Klebsiella pneumoniae 87 45 75 69 41 100 74 67
Acinetobacter spp 69 29 69 74 25 98 63 80
Atypical E.coli 85 58 45 68 39 100 71 75

[i] aMS- methicillin- sensitive; bMR- methicillin resistant

[ii] AK-amikacin; CTX- cefotaxime; CIP- ciprofloxacin; COT- cotrimoxazole; AMC-amoxicillin/ clavulanic acid, IPM- imipeneam, ATM- aztreonam, CES-cefoperazone/sulbactam

Discussion

In our study, diabetics mostly in the aged category were more prone and susceptible for the diabetic foot infections. This was found to be in agreement with the study from Bangladesh which too reports most of their patients being in the older category.10 The mean age of the patients was 52.31years which was similar to the 55 mean age of the subjects reported from the Bangladesh study.10

Isolation of only aerobic pathogens were found in both the diabetic and non-diabetic categories which included gram positive and gram negative organisms owing to the aerobic incubation conditions followed in the laboratory whereas other studies showed isolation of anaerobic pathogens also in the diabetic foot infections.11

 Among the isolated pathogens Staphylococcus aureus was the commonest gram positive bacteria and in the gram negative category Pseudomonas aeruginosa was the frequently isolated microbial pathogen in the diabetic foot ulcer patients as well as in non-diabetic patients. These findings were similar to the many other Indian and international studies carried out among the diabetic foot infections.12, 13

Diabetic foot infections are considered to be polymicrobial in nature. This polymicrobial infection rate was comparable to the other studies where polymicrobial isolation of pathogens were more when compared to the monomicrobial organisms.14, 15 Also, preponderance of the organisms isolated is gram positive followed by gram negative and anaerobic pathogens.16, 17, 18

Like other reported studies, our findings state presence of antibiotic resistant organisms like methicillin resistance and ESBL producers more common among the diabetic people on comparing with non-diabetic patients.18

The polymicrobial nature of the diabetic foot infections reveals indirect relationship between the occurrence of bacterial infections and increased duration of the diabetic foot ulcer which results in many complications like amputation of the affected parts.

Effective antimicrobial usage is prerequisite in the control and care of the diabetic foot infections. Antibiotic susceptibility pattern of the commonly isolated organisms are low and none of the isolates prove 100% efficient in treating the infections. Also, like other reported studies there is presence of multiple antibiotic resistance in the isolated microorganisms.19, 20 This low susceptibility for antimicrobial agents attributes for the extensive usage of the available treatment options without the judicious thinking.

Though, Pseudomonas species show the highest rate of isolation among diabetic as well as non-diabetic like other studies, we also recommend adequate care like avoiding moisture frequent wound dressings etc. to eradicate this pathogen.21 Also, overall incidence of Staphylococcus spp is considered to be more as stated in other similar studies among diabetic as well as among non-diabetic patients.22

Our findings are comparable to a recent study done suggesting more chronic and complicated diabetic foot infections are by gram negative pathogens predominantly.23

Limitation of the Study

Comprehensive antimicrobial coverage in treating diabetic foot infections need to be studied on a larger group of patients. Isolation of anaerobic pathogens and their role in the pathogenesis of diabetic foot infections need to be emphasized.

Conclusion

It is concluded through our study that ppolymicrobial infections are more prevalent among diabetic patients when compared to non-diabetic group of patients. Hence, early diagnosis of diabetic wound infections with proper therapy and care is essential in order to avoid complications and deep seeded systemic infections among diabetic patients.

Acknowledgement

Authors thank Central Laboratory, Department of Microbiology, SVMCH&RC in helping to carry out the research work.

Source of Funding

Self.

Conflict or Interest

None.

References

1 

R N Jones T R Fritsche H S Sader J E Ross LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers)Diagnostic Microbiol Infect Dis200759309326

2 

Mousumi Karmaker Santonu K. Sanyal Munawar Sultana M.A. Hossain Association of bacteria in diabetic and non-diabetic foot infection – An investigation in patients from BangladeshJ Infect Public Health20169267771876-0341Elsevier BV

3 

V Rani J Nithyalakshmi A comparative study of Diabetic and Non-diabetic wound infections with special reference to MRSA and ESBLInt J Curr Microbiol App Sci201431254654

4 

Soeb Jankhwala Suman Singh Sarita Nayak A comparative study of profile of infections in diabetic and non-diabetic PatientsInt J Med Sci Public Health20143898262320-4664ScopeMed Publishing

5 

Monil Singhai Ashok Kumar PawanKumar Jha Rajeev Goyal Vinita Rawat Bacteriological and resistance profile in isolates from diabetic patientsNorth Am J Med Sci201245631947-2714Medknow

6 

Performance standards for antimicrobial susceptibility testing 27th information supplement201737100127Clinical Laboratory Standard Institute

7 

Deepti Rawat Deepthi Nair Extended-spectrum ß-lactamases in gram negative bacteriaJ Glob Infect Dis20102263740974-777XMedknow

8 

J H Sun J S Tsai C H Huang C H Lin H M Yang Y S Chan Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classificationDiabetes Res Clin Pract20129535863

9 

Saba Noor Mohammad Zubair Jamal Ahmad Diabetic foot ulcer—A review on pathophysiology, classification and microbial etiologyDiabetes Metab Syndr: Clin Res Rev20159319291871-4021Elsevier BV

10 

Mousumi Karmaker Santonu K. Sanyal Munawar Sultana M.A. Hossain Association of bacteria in diabetic and non-diabetic foot infection – An investigation in patients from BangladeshJ Infect Public Health201693267771876-0341Elsevier BV

11 

C B Carvalho R M Neto L P Aragoa M M Oliveira M B Nogueira A C Forti Diabetic foot ulcer infection, bacteriological analysis of 141 patientsArq Bras Endocrinol Metab201448398405

12 

P Ramakant A Verma R Misra K Prasad Changing microbiological profile of pathogenic bacteria in diabetic foot ulcerDiabetol20115415864

13 

A O Almobarak H Awadalla M Osman M H Ahmed Prevalence of diabetic foot ulceration and associated risk factors: an old and still major public health problem in Khartoum, Sudan?. Ann Transl Med20175Khartoum, Sudan

14 

Ofonime M. Ogba Emmanuel Nsan Eyam S. Eyam Aerobic bacteria associated with diabetic foot ulcers and their susceptibility patternBiomed Dermatol201932398-846010.1186/s41702-019-0039-xSpringer Science and Business Media LLC

15 

Obumneme Anyim Christian Okafor Ekenechukwu Young Ijeoma Obumneme-Anyim Chidimma Nwatu Pattern and microbiological characteristics of diabetic foot ulcers in a Nigerian tertiary hospitalAfr Health Sci2019191617271680-6905African Journals Online (AJOL)

16 

B A Lipsky A R Berendt P B Cornia J C Pile E J Peters D G Armstrong Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infectionsClin Infect Dis20125413273

17 

E Everett N Mathioudakis Update on management of diabetic foot ulcersAnn New York Acad Sci14111153

18 

Liza R. Braun Whitney A. Fisk Hadar Lev-Tov Robert S. Kirsner Roslyn R. Isseroff Diabetic Foot Ulcer: An Evidence-Based Treatment UpdateAm J Clin Dermatol201415267811175-0561, 1179-1888Springer Science and Business Media LLC

19 

Ramya Kateel Alfred J. Augustine Shivananda Prabhu Sheetal Ullal Manohar Pai Prabha Adhikari Clinical and microbiological profile of diabetic foot ulcer patients in a tertiary care hospitalDiabetes Metab Syndr: Clin Res Rev201812127301871-4021Elsevier BV

20 

B Belefquih M Frikh Y Benlahlou A Maleh L Jadid F Bssaibis M Ghazouani B Chagar J Lamsaouri A Lemnouer M Elouennass Diabetic Foot Infection in Morocco: Microbiological Profile. Wounds: a compendium of clinical research and practice2016288998

21 

P Shanmugam L S Susan The bacteriology of diabetic foot ulcers, with a special reference to multidrug resistant strainsJ Clin Diagnostic Res: JCDR2013734415

22 

S Chhibber T Kaur S Kaur Co-therapy using lytic bacteriophage and linezolid: effective treatment in eliminating methicillin resistant Staphylococcus aureus (MRSA) from diabetic foot infectionsPloS One2013856022

23 

Vedat Turhan Mesut Mutluoglu Ali Acar Mustafa Hatipoglu Yalcın Onem Gunalp Uzun Increasing incidence of Gram-negative organisms in bacterial agents isolated from diabetic foot ulcersJ Infect Dev Ctries2013710707121972-2680Journal of Infection in Developing Countries



jats-html.xsl


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.

  • Article highlights
  • Article tables
  • Article images

View Article

PDF File   Full Text Article


Copyright permission

Get article permission for commercial use

Downlaod

PDF File   XML File   ePub File


Digital Object Identifier (DOI)

Article DOI

https://doi.org/10.18231/j.ijmr.2020.037


Article Metrics






Article Access statistics

Viewed: 1423

PDF Downloaded: 573